Fluid Simulation of a Transcatheter Aortic Valve Deployment into a Patient-Specific Aortic Root

被引：0
作者：
Sirois E. [1 ]
Wang Q. [1 ]
Sun W. [1 ]
机构：
[1] Tissue Mechanics Lab, Biomedical Engineering Program, Mechanical Engineering Department, University of Connecticut, Storrs, CT 06269-3139
来源：
Cardiovascular Engineering and Technology | 2011年 / 2卷 / 3期
基金：
美国国家科学基金会;
关键词：
Computational fluid dynamics; Finite element analysis; Patient-specific modeling; Transcatheter percutaneous aortic valve;
D O I：
10.1007/s13239-011-0037-7
中图分类号：
学科分类号：
摘要：
Successful transcatheter aortic valve (TAV) deployment and function are heavily reliant on the implant-host tissue interaction. Many adverse events observed clinically in TAV procedures such as impairment of coronary artery flow, paravalvular leak, and access site injury could be attributed to improper TAV deployment and interaction with the aortic root. In this study, we performed a computational analysis of the TAV-aortic root interaction, particularly the hemodynamics before and after TAV deployment. Utilizing a recently developed computational TAV model, we simulated the deployment of this TAV into a 68 year old male patient. The geometry of the patient's aortic valve and root were extracted from clinical CT images. From the simulation results, we obtained a peak transvalvular pressure drop of 78.45 and 25.27 mmHg before and after the TAV deployment, respectively. The mean systolic ejection transvalvular pressure reduced from 45.8 to 7.55 mmHg and effective orifice area (EOA) increased from 0.53 to 1.595 cm2 following the TAV intervention. The altered flow pattern following TAV intervention resulted in a significant pressure drop in the vicinity of the sinuses of Valsalva, and a corresponding decrease in percentage of cardiac output reaching the coronary arteries from 5.14 to 4.07% from pre- to post-TAV deployment. In conclusion, the developed computational models allow for a quantitative analysis of the hemodynamics before and after TAV intervention, and thus could be an enabling tool for patient screening and TAV design improvement. © 2011 Biomedical Engineering Society.
引用
收藏
页码：186 / 195
页数：9
相关论文
共 37 条
  • [1] Aguado-Sierra J., Hadjilizou N., Davies J.E., Francis D., Mayet J., Parker K.H., Pressure reservoir-wave separation applied to the coronary arterial data, In: Conference Proceedings of the IEEE Engineering in Medicine and Biology Society, pp. 2693-2696, (2007)
  • [2] Azadani A., Jaussaud N., Matthews P., Ge L., Chuter T., Tseng E., Energy loss due to paravalvular leak with transcatheter aortic valve implantation, Ann. Thorac. Surg., 88, 6, pp. 1857-1863, (2009)
  • [3] Azadani A., Jaussaud N., Matthews P., Ge L., Chuter T., Tseng E., Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses, Interact. Cardiovasc. Thorac. Surg., 11, 1, pp. 70-77, (2010)
  • [4] Bauer F., Eltchaninoff H., Tron C., Lesault P., Agatiello C., Nercolini D., Derumeaux G., Cribier A., Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis, Circulation, 110, 11, pp. 1473-1476, (2004)
  • [5] Ben-Dor I., Goldstein S., Waksman R., Satler L., Li Y., Syed A., Maluenda G., Collins S., Suddath W., Torguson R., Xue Z., Kaneshige K., Okubagzi P., Wang Z., Kent K., Pichard A., Effects of percutaneous aortic valve replacement on coronary blood flow assessed with transesophageal Doppler echocardiography in patients with severe aortic stenosis, Am. J. Cardiol., 104, 6, pp. 850-855, (2009)
  • [6] Berry C., Asgar A., Lamarche Y., Marcheix B., Couture P., Basmadjian A., Ducharme A., Laborde J., Cartier R., Bonan R., Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System, Catheter Cardiovasc Interv., 70, 4, pp. 610-616, (2007)
  • [7] Bonow R.O., Carabello B.A., Chatterjee K., de Leon Jr. A.C., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S., AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed
  • [8] Clavel M., Webb J., Pibarot P., Altwegg L., Dumont E., Thompson C., de Larochelliere R., Doyle D., Masson J., Bergeron S., Bertrand O., Rodes-Cabau J., Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis, J. Am. Coll. Cardiol., 53, 20, pp. 1892-1893, (2009)
  • [9] Culliford A.T., Galloway A.C., Colvin S.B., Grossi E.A., Baumann F.G., Esposito R., Ribakove G.H., Spencer F.C., Aortic valve replacement for aortic stenosis in persons aged 80 years and over, Am. J. Cardiol., 67, 15, pp. 1256-1260, (1991)
  • [10] Dwyer H., Matthews P., Azadani A., Ge L., Guy T., Tseng E., Migration forces of transcatheter aortic valves in patients with noncalcific aortic insufficiency, J. Thorac. Cardiovasc. Surg., 138, 5, pp. 1227-1233, (2009)
1234